209 related articles for article (PubMed ID: 17549482)
21. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.
Treusch M; Vonthein R; Baur M; Günaydin I; Koch S; Stübiger N; Eckstein AK; Peter HH; Ness T; Zierhut M; Kötter I
Rheumatology (Oxford); 2004 Oct; 43(10):1275-82. PubMed ID: 15252211
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
[TBL] [Abstract][Full Text] [Related]
24. Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a.
Aydinoglu-Candan Ö; Araz-Erşan B; Gul A; Badur S; Tugal-Tutkun I
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):457-65. PubMed ID: 25500983
[TBL] [Abstract][Full Text] [Related]
25. Dendritic cell subsets and type I interferon system in Behçet's disease: does functional abnormality in plasmacytoid dendritic cells contribute to Th1 polarization?
Pay S; Simsek I; Erdem H; Pekel A; Musabak U; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S34-40. PubMed ID: 17949549
[TBL] [Abstract][Full Text] [Related]
26. 4-Octyl Itaconate Inhibits Proinflammatory Cytokine Production in Behcet's Uveitis and Experimental Autoimmune Uveitis.
Wang Q; Ye X; Tan S; Jiang Q; Su G; Pan S; Li H; Cao Q; Yang P
Inflammation; 2024 Jun; 47(3):909-920. PubMed ID: 38183531
[TBL] [Abstract][Full Text] [Related]
27. Novel effects of On-Chung-Eum, the traditional plant medicine, on cytokine production in human mononuclear cells from Behçet's.
Kim MS; Kim SO; Lim WK; Lee JM; Hwang CY; Cho KH; Kim HM
Immunopharmacol Immunotoxicol; 2003 Feb; 25(1):65-72. PubMed ID: 12675200
[TBL] [Abstract][Full Text] [Related]
28. Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A.
Chi W; Yang P; Zhu X; Wang Y; Chen L; Huang X; Liu X
Mol Vis; 2010 May; 16():880-6. PubMed ID: 20508866
[TBL] [Abstract][Full Text] [Related]
29. [Production of Th1/Th2 cytokines and nitric oxide in Behçet's uveitis and idiopathic uveitis].
Guenane H; Hartani D; Chachoua L; Lahlou-Boukoffa OS; Mazari F; Touil-Boukoffa C
J Fr Ophtalmol; 2006 Feb; 29(2):146-52. PubMed ID: 16523155
[TBL] [Abstract][Full Text] [Related]
30. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.
Chi W; Zhu X; Yang P; Liu X; Lin X; Zhou H; Huang X; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3058-64. PubMed ID: 18579762
[TBL] [Abstract][Full Text] [Related]
31. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M
Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479
[TBL] [Abstract][Full Text] [Related]
32. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12.
Frassanito MA; Dammacco R; Cafforio P; Dammacco F
Arthritis Rheum; 1999 Sep; 42(9):1967-74. PubMed ID: 10513814
[TBL] [Abstract][Full Text] [Related]
33. Pronounced interferon-alpha production from plasmacytoid dendritic cells in patients with Behçet's disease following CpG D ODN stimulation.
Pay S; Pekel A; Simsek I; Musabak U; Erdem H; Dinc A; Kose O
Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S37-42. PubMed ID: 19796531
[TBL] [Abstract][Full Text] [Related]
34. Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.
Wang C; Tian Y; Ye Z; Kijlstra A; Zhou Y; Yang P
Arthritis Res Ther; 2014 May; 16(3):R117. PubMed ID: 24887071
[TBL] [Abstract][Full Text] [Related]
35. Uric acid increases IL-1β secretion and Caspase-1 activation in PBMCs of Behçet's disease patients: The in vitro immunomodulatory effect of xanthine oxidase inhibitor Allopurinol.
Chekaoui A; Belguendouz H; Lahmar K; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C
Int Immunopharmacol; 2020 Mar; 80():106119. PubMed ID: 31927504
[TBL] [Abstract][Full Text] [Related]
36. Effects of azithromycin on intracellular cytokine responses and mucocutaneous manifestations in Behçet's disease.
Mumcu G; Inanç N; Özdemir FT; Tulunay A; Ekşioğlu-Demiralp E; Ergun T; Direskeneli H
Int J Dermatol; 2013 Dec; 52(12):1561-6. PubMed ID: 23879671
[TBL] [Abstract][Full Text] [Related]
37. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
38. T and NK cell subset changes with microbial extracts and human HSP60-derived peptides in Behçet's disease.
Kibaroglu A; Eksioglu-Demiralp E; Akoglu T; Direskeneli H
Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S59-63. PubMed ID: 15515788
[TBL] [Abstract][Full Text] [Related]
39. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.
El-Asrar AM; Struyf S; Kangave D; Al-Obeidan SS; Opdenakker G; Geboes K; Van Damme J
Clin Immunol; 2011 May; 139(2):177-84. PubMed ID: 21334264
[TBL] [Abstract][Full Text] [Related]
40. Dual effects of testosterone in Behcet's disease: implications for a role in disease pathogenesis.
Yavuz S; Akdeniz T; Hancer V; Bicakcigil M; Can M; Yanikkaya-Demirel G
Genes Immun; 2016 Sep; 17(6):335-41. PubMed ID: 27467286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]